BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8142113)

  • 1. Adapalene, a new chemical entity with retinoid activity.
    Bernard BA
    Skin Pharmacol; 1993; 6 Suppl 1():61-9. PubMed ID: 8142113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tretinoin or adapalene in acne vulgaris: an overview.
    Jain S
    J Dermatolog Treat; 2004 Jul; 15(4):200-7. PubMed ID: 15764031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne.
    Brogden RN; Goa KE
    Drugs; 1997 Mar; 53(3):511-9. PubMed ID: 9074847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of adapalene in the treatment of acne vulgaris.
    Irby CE; Yentzer BA; Feldman SR
    J Adolesc Health; 2008 Nov; 43(5):421-4. PubMed ID: 18848668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of adapalene.
    Michel S; Jomard A; Démarchez M
    Br J Dermatol; 1998 Oct; 139 Suppl 52():3-7. PubMed ID: 9990413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on adapalene in acne vulgaris.
    Waugh J; Noble S; Scott LJ
    Am J Clin Dermatol; 2004; 5(5):369-71. PubMed ID: 15554742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne.
    Czernielewski J; Michel S; Bouclier M; Baker M; Hensby JC
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():5-12. PubMed ID: 11843234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new concept of drug delivery for acne.
    Shroot B; Michel S; Allec J; Chatelus A; Wagner N
    Dermatology; 1998; 196(1):165-70. PubMed ID: 9557255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and chemistry of adapalene.
    Shroot B; Michel S
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S96-103. PubMed ID: 9204085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
    Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
    Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
    Ioannides D; Rigopoulos D; Katsambas A
    Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients.
    Clucas A; Verschoore M; Sorba V; Poncet M; Baker M; Czernielewski J
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S116-8. PubMed ID: 9204089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients.
    Caron D; Sorba V; Kerrouche N; Clucas A
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S110-2. PubMed ID: 9204087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical retinoids in acne vulgaris: update on efficacy and safety.
    Thielitz A; Gollnick H
    Am J Clin Dermatol; 2008; 9(6):369-81. PubMed ID: 18973403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials.
    Cunliffe WJ; Caputo R; Dreno B; Förström L; Heenen M; Orfanos CE; Privat Y; Robledo Aguilar A; Meynadier J; Alirezai M; Jablonska S; Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart JM; Swinyer L; Whitmore C; Czernielewski J; Verschoore M
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S126-34. PubMed ID: 9204091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids.
    Bikowski JB
    J Drugs Dermatol; 2005; 4(1):41-7. PubMed ID: 15696984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of epidermal histological changes induced by topical retinoids and CD271 in the rhino mouse model using a standardized image analysis technique.
    Bouclier M; Chatelus A; Ferracin J; Delain C; Shroot B; Hensby CN
    Skin Pharmacol; 1991; 4(2):65-73. PubMed ID: 1831625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new topical retinoid--why a new topical acne therapy?
    Cunliffe WJ
    Br J Dermatol; 1998 Oct; 139 Suppl 52():1-2. PubMed ID: 9990412
    [No Abstract]   [Full Text] [Related]  

  • 19. Adapalene gel 0.1%: effective and well tolerated in the topical treatment of acne vulgaris in Chinese patients.
    Zhu XJ; Tu P; Zhen J; Duan YQ
    Cutis; 2001 Oct; 68(4 Suppl):55-9. PubMed ID: 11845949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
    Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
    J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.